Breaking News

Neumora Therapeutics Inc (NMRA)

NASDAQ

Add to/Remove from Watchlist Add to Watchlist

9.67 +0.04 +0.42%

17/05 - Closed. Currency in USD ( Disclaimer )

After Hours

9.67

-0.00

-0.00%

16:01:38 - Real-time Data

Type: Equity

Market: United States

Volume: 320,321
Bid/Ask: 0.00 / 0.00
Day's Range: 9.38 - 9.70

Neumora Therapeutics Inc Company Profile

Get an in-depth profile of Neumora Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

124

Equity Type

ORD

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer’s disease; and NMRA-266, which is in the phase 1 clinical trial for the treatment of schizophrenia and other neuropsychiatric disorders. In addition, its preclinical phase product includes NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson’s disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.

Contact Information

Address 490 Arsenal Way Suite 200
Watertown, 02472
United States

Phone 857 760 0900

Fax -

Web www.neumoratx.com

Top Executives

Name	Age	Since	Title
Gaurav Singal	-	-	Member of Technology Advisory Board
Patrick Sullivan	-	-	Member of Scientific Advisory Board
Kristina M. Burow	51	2020	Independent Director
Diego A. Pizzagalli	-	-	Member of Technology Advisory Board
John D. Murray	-	-	Member of Technology Advisory Board
Sandeep Robert Datta	-	-	Member of Scientific Advisory Board
Andrew Trister	-	-	Member of Technology Advisory Board
Mark Daly	-	-	Member of Scientific Advisory Board
Richard Huganir	-	-	Member of Scientific Advisory Board
Iain McFadyen	-	-	Member of Technology Advisory Board
Edward Roberts	-	-	Member of Scientific Advisory Board
Benjamin Neale	-	-	Member of Scientific Advisory Board
John Krystal	-	-	Member of Scientific Advisory Board
Maykin Ho	71	2021	Independent Director
Alex Wiltschko	-	2023	Member of Technology Advisory Board
Hugh Rosen	65	-	Member of Scientific Advisory Board
Beth Stevens	-	-	Member of Scientific Advisory Board
Alan Anticevic	-	-	Member of Technology Advisory Board
Paul L. Berns	57	2020	Co-Founder & Executive Chairman
Matthew K. Fust	59	2020	Independent Director
Bernardo L. Sabatini	-	-	Member of Scientific Advisory Board
David A. Piacquad	67	2023	Independent Director
Morgan H. Sheng	66	-	Member of Scientific Advisory Board
Alaa Halawa	41	2022	Independent Director
Edward M. Scolnick	83	-	Member of Scientific Advisory Board
Henry O. Gosebruch	51	2023	President, CEO & Director

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

NMRA Comments

Write your thoughts about Neumora Therapeutics Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	40,055.7	+52.1	+0.13%
US 500	5,311.4	+8.1	+0.15%
Dow Jones	40,003.59	+134.21	+0.34%
S&P 500	5,303.27	+6.17	+0.12%
Nasdaq	16,685.97	-12.36	-0.07%
S&P 500 VIX	11.99	0.00	0.00%
Dollar Index	104.410	+0.040	+0.04%

Crude Oil WTI	79.32	-0.26	-0.33%
Brent Oil	83.76	-0.24	-0.29%
Natural Gas	2.634	-0.004	-0.15%
Gold	2,422.50	+5.10	+0.21%
Silver	31.600	+0.341	+1.09%
Copper	5.0795	+0.0045	+0.09%
US Soybeans	1,228.50	+1.25	+0.10%

U.S. 10Y	4.418	-0.002	-0.05%
U.S. 30Y	4.562	+0.001	+0.01%
U.S. 5Y	4.441	0.000	0.00%
U.S. 3M	5.443	+0.054	+0.99%
US 10Y T-Note	109.17	-0.02	-0.01%
Euro Bund	130.69	0.00	0.00%
10-2 Yield Spread	-40.69	+1.34	+-3.19%

Apple	189.87	+0.03	+0.02%
Alphabet A	176.06	+1.88	+1.08%
Tesla	177.46	+2.62	+1.50%
Amazon.com	184.70	+1.07	+0.58%
Netflix	621.10	+10.58	+1.73%
Meta Platforms	471.91	-1.32	-0.28%
Bank of America	39.31	+0.09	+0.23%

Recent Quotes

Name	Price	Chg.	Chg. %
NMRA	9.67	+0.04	+0.42%
William Blair SIC.	542.170	-6.230	-1.14%
NAP	3.86	0.00	0%
BXO	2.59	0.00	0.00%
Templeton Global .	1,092.030	+0.830	+0.08%
RALYH	195.500	+2.500	+1.30%
Abanca Renta Vari.	6.37	+0.01	+0.20%
EMSNz	763.00	-2.00	-0.26%

Market Movers

Name	Last	Chg. %	Vol.
TSLA	177.46	+1.50%	77.09M
AMD	164.47	+1.14%	65.68M
AAPL	189.87	+0.02%	41.23M
NVDA	924.79	-1.99%	34.05M
AMZN	184.70	+0.58%	32.25M
MSFT	420.21	-0.19%	15.11M
BRKa	629,070	+0.64%	14.37K

Name	Last	Chg. %	Vol.
VLO	166.14	+4.82%	3.59M
FCX	54.25	+4.25%	15.84M
CB	274.43	+3.60%	3.46M
TSCO	285.67	+3.42%	2.18M
SBUX	77.85	+3.41%	14.39M
DD	79.92	+3.02%	2.18M
MPC	179.73	+2.84%	2.61M

Name	Last	Chg. %	Vol.
PARA	12.02	-4.91%	17.05M
DLTR	117.31	-3.29%	2.36M
LRCX	912.07	-3.27%	910.12K
DG	142.17	-3.02%	2.29M
STX	95.27	-3.02%	2.66M
ILMN	111.07	-2.96%	1.04M
JBHT	164.80	-2.77%	966.66K